Considering that PD-L1 expression correlates inversely with CAR-T tumor retention, the human NIS was used to quantify tumor retention of pan-ErbB family targeted CAR-T by PET, ex vivo and non-invasively. The gene discussed is EGFR; the disease is neoplasm.